Mersana Therapeutics
MRSN
$3.42
Share price
1.93%
Change (1 day)
-21.80%
Change (1 year)
Categories
P/S ratio for Mersana Therapeutics (MRSN)
P/S ratio as of May 2024 (TTM): 11.2
According to Mersana Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.1554. At the end of 2023 the company had a P/S ratio of 7.59.
P/S ratio history for Mersana Therapeutics from 2017 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 7.59 | -65.49% |
| 2022 | 22.0 | -99.78% |
| 2021 | > 1000 | 362.35% |
| 2020 | > 1000 | 35511.31% |
| 2019 | 6.17 | -30.99% |
| 2018 | 8.95 | -58.01% |
| 2017 | 21.3 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |